{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:29:33Z","timestamp":1793478573496,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009110","name":"Natural Science Foundation of Xinjiang Uygur Autonomous Region","doi-asserted-by":"publisher","award":["2024D01E22"],"award-info":[{"award-number":["2024D01E22"]}],"id":[{"id":"10.13039\/100009110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82560576"],"award-info":[{"award-number":["82560576"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32260186"],"award-info":[{"award-number":["32260186"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.prp.2026.156683","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:00:42Z","timestamp":1788879642000},"page":"156683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["USP10 is associated with TUBA1B protein stability, PI3K\/AKT phosphorylation changes, and progression of triple-negative breast cancer"],"prefix":"10.1016","volume":"288","author":[{"given":"Haotian","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0048-6835","authenticated-orcid":false,"given":"Yiyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyidan","family":"Aimaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4531-8958","authenticated-orcid":false,"given":"Chenming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2026.156683_bib1","doi-asserted-by":"crossref","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","article-title":"The PRIDE database at 20 years: 2025 update","volume":"53","author":"Perez-Riverol","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.prp.2026.156683_bib2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prp.2026.156683_bib3","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prp.2026.156683_bib4","first-page":"477","article-title":"Breast cancer statistics 2024","volume":"74","author":"Giaquinto","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prp.2026.156683_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157368","article-title":"Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection","volume":"11","author":"Lehmann","year":"2016","journal-title":"PLoS. One"},{"key":"10.1016\/j.prp.2026.156683_bib6","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast cancer treatment","volume":"321","author":"Waks","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.prp.2026.156683_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1405491","article-title":"Advancements and challenges in triple-negative breast cancer: a comprehensive review of therapeutic and diagnostic strategies","volume":"14","author":"Xiong","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2026.156683_bib8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41580-020-0214-3","article-title":"The tubulin code and its role in controlling microtubule properties and functions","volume":"21","author":"Janke","year":"2020","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.prp.2026.156683_bib9","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3390\/cancers10080274","article-title":"Genetics and expression profile of the tubulin gene superfamily in breast cancer subtypes and its relation to taxane resistance","volume":"10","author":"Nami","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2026.156683_bib10","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.cell.2018.05.018","article-title":"Tubulin posttranslational modifications and emerging links to human disease","volume":"173","author":"Magiera","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.prp.2026.156683_bib11","first-page":"858","article-title":"Tubulin alpha 1b is associated with the immune cell infiltration and the response of HCC patients to immunotherapy","volume":"12","author":"Hu","year":"2022","journal-title":"Diagn. (Basel)"},{"key":"10.1016\/j.prp.2026.156683_bib12","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9809347","article-title":"The expression and potential role of tubulin alpha 1b in Wilms' tumor","volume":"2020","author":"Xu","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.prp.2026.156683_bib13","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190235","article-title":"Screening of disorders associated with osteosarcoma by integrated network analysis","volume":"39","author":"Dou","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.prp.2026.156683_bib14","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1007\/s10620-013-2692-z","article-title":"Increased \u03b1-tubulin1b expression indicates poor prognosis and resistance to chemotherapy in hepatocellular carcinoma","volume":"58","author":"Lu","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.prp.2026.156683_bib15","doi-asserted-by":"crossref","first-page":"8201","DOI":"10.1038\/s41598-024-58982-z","article-title":"Tubulin alpha-1b chain was identified as a prognosis and immune biomarker in pan-cancer combing with experimental validation in breast cancer","volume":"14","author":"Wang","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2026.156683_bib16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","article-title":"The ubiquitin system","volume":"67","author":"Hershko","year":"1998","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.prp.2026.156683_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","article-title":"Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2026.156683_bib18","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrm2731","article-title":"Breaking the chains: structure and function of the deubiquitinases","volume":"10","author":"Komander","year":"2009","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.prp.2026.156683_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagrm.2023.194979","article-title":"Ubiquitination and deubiquitination: implications on cancer therapy","volume":"1866","author":"Dagar","year":"2023","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"10.1016\/j.prp.2026.156683_bib20","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.cell.2009.12.032","article-title":"USP10 regulates p53 localization and stability by deubiquitinating p53","volume":"140","author":"Yuan","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.prp.2026.156683_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101088","article-title":"The deubiquitinase USP10 restores PTEN activity and inhibits non-small cell lung cancer cell proliferation","volume":"297","author":"He","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2026.156683_bib22","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1038\/s41418-019-0458-7","article-title":"The deubiquitinase USP10 regulates KLF4 stability and suppresses lung tumorigenesis","volume":"27","author":"Wang","year":"2020","journal-title":"Cell. Death Differ."},{"key":"10.1016\/j.prp.2026.156683_bib23","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1186\/s12885-024-12549-3","article-title":"System-wide identification of novel de-ubiquitination targets for USP10 in gastric cancer metastasis through multi-omics screening","volume":"24","author":"Zeng","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2026.156683_bib24","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.7150\/ijbs.92278","article-title":"USP10 promotes pancreatic ductal adenocarcinoma progression by attenuating FOXC1 protein degradation to activate the WNT signaling pathway","volume":"20","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.prp.2026.156683_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13578-024-01291-9","article-title":"Deubiquitinase USP10 promotes osteosarcoma autophagy and progression through regulating GSK3\u03b2-ULK1 axis","volume":"14","author":"Feng","year":"2024","journal-title":"Cell. Biosci."},{"key":"10.1016\/j.prp.2026.156683_bib26","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3390\/genes13050831","article-title":"USP10 as a potential therapeutic target in human cancers","volume":"13","author":"Tao","year":"2022","journal-title":"Genes. (Basel)"},{"key":"10.1016\/j.prp.2026.156683_bib27","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s12282-024-01567-5","article-title":"PI3K\/AKT\/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer","volume":"31","author":"Zhang","year":"2024","journal-title":"Breast Cancer"},{"key":"10.1016\/j.prp.2026.156683_bib28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2026.156683_bib29","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ccell.2018.03.014","article-title":"A comprehensive pan-cancer molecular study of gynecologic and breast cancers","volume":"33","author":"Berger","year":"2018","journal-title":"Cancer Cell."},{"key":"10.1016\/j.prp.2026.156683_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/science.aal3321","article-title":"A subcellular map of the human proteome","volume":"356","author":"Thul","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.prp.2026.156683_bib31","unstructured":"Human Protein Atlas, The Human Protein Atlas database, https:\/\/www.proteinatlas.org, 2026 (accessed 6 May 2026)."},{"key":"10.1016\/j.prp.2026.156683_bib32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","article-title":"Treatment landscape of triple-negative breast cancer: expanded options, evolving needs","volume":"19","author":"Bianchini","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.prp.2026.156683_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115864","article-title":"USP10 promotes the progression of triple-negative breast cancer by enhancing the stability of TCF4 protein","volume":"218","author":"Yang","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.prp.2026.156683_bib34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.7150\/ijbs.76798","article-title":"Stabilization of IGF2BP1 by USP10 promotes breast cancer metastasis via CPT1A in an m6A-dependent manner","volume":"19","author":"Shi","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.prp.2026.156683_bib35","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41568-023-00633-y","article-title":"Deubiquitinases in cancer","volume":"23","author":"Dewson","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2026.156683_bib36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-biochem-060310-170328","article-title":"The ubiquitin code","volume":"81","author":"Komander","year":"2012","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.prp.2026.156683_bib37","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nrm3394","article-title":"Atypical ubiquitylation: the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages","volume":"13","author":"Kulathu","year":"2012","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.prp.2026.156683_bib38","doi-asserted-by":"crossref","first-page":"E1401","DOI":"10.1073\/pnas.1716673115","article-title":"K63 ubiquitylation triggers proteasomal degradation by seeding branched ubiquitin chains","volume":"115","author":"Ohtake","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.prp.2026.156683_bib39","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12943-026-02568-y","article-title":"piR-1170 drives brain metastasis and immune evasion via WTAP-mediated m6A methylation reprogramming in triple-negative breast cancer","volume":"25","author":"Luo","year":"2026","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2026.156683_bib40","doi-asserted-by":"crossref","first-page":"47089","DOI":"10.31083\/FBL47089","article-title":"Integrated single-cell and bulk RNA sequencing identifies SERPING1 as a biomarker of immune infiltration and prognosis in triple-negative breast cancer","volume":"31","author":"Shang","year":"2026","journal-title":"Front. Biosci. (Landmark Ed. )"},{"key":"10.1016\/j.prp.2026.156683_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218192","article-title":"Copper orchestrates triple-negative breast cancer progression via the STEAP3-dependent CDK16-JAK1 activation","volume":"639","author":"Duan","year":"2026","journal-title":"Cancer Lett."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826003365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826003365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T19:37:48Z","timestamp":1793475468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826003365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":41,"alternative-id":["S0344033826003365"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156683","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"USP10 is associated with TUBA1B protein stability, PI3K\/AKT phosphorylation changes, and progression of triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156683","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156683"}}